Tag: Barhemsys

FDA, Industry, Regulations, Vaccines

FDA Approves Barhemsys (amisulpride) for the Treatment and Prevention of PONV

February 27, 2020


Acacia Pharma Group plc (“Acacia Pharma” or the “Company”), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures, or cancer […]